期刊文献+

藜芦胺类似物的合成及体外抗肿瘤活性研究 被引量:4

Synthesis of Veratramine Analogs and Evaluation of Their Antiproliferative Activities on Cancer Cell in vitro
下载PDF
导出
摘要 以黎芦属植物中含量丰富的甾体生物碱藜芦胺(Ⅰ)为原料,经结构修饰,共得到5种藜芦胺类似物Ⅱ~Ⅵ。经核磁共振谱、质谱确定化合物结构。以已知的Hedgehog信号通路抑制剂环巴胺为阳性对照,采用人胃癌细胞SGC-7901和人胰腺癌细胞Aspc-1进行体外抑制肿瘤细胞增殖活性筛选。结果表明,化合物Ⅳ、Ⅴ、Ⅵ的抑制肿瘤细胞增殖活性优于环巴胺。初步构效关系研究表明,在藜芦胺的哌啶环上引入烟酸及对硝基苯甲酰基团,可显著提高其抗肿瘤活性。 The steroidal alkaloid veratramine,which is rich in Veratrum plants,was taken as starting material for structure modification. Five veratramine analogs Ⅱ ~ Ⅵ were obtained. Their structures were determined by means of MS and NMR. Cyclopamine,the first inhibitor of Hedgehog signaling pathway,was used as the positive control,and the antiproliferative activities of yielded compounds on human gastric cancer cell SGC- 7901 and human pancreatic cancer cell Aspc- 1 in vitro were carried out. The results showed that the antiproliferative activities of compounds Ⅳ,Ⅴand Ⅵ were much more potent than that of cyclopamine. Preliminary study of the structure-activity relationship suggested that antiproliferative activities of veratramine analogs could be increased by introducing nicotinic acid and pnitrophenyl formyl groups at piperidine ring of veratramine.
出处 《精细化工》 EI CAS CSCD 北大核心 2015年第11期1266-1270,共5页 Fine Chemicals
基金 国家自然科学基金(20872011) 中央高校基本科研业务费专项资金〔DUT13RC(3)45 DUT15RC(4)07〕 教育部留学回国人员科研启动基金(49)~~
关键词 HEDGEHOG信号通路 藜芦胺 环巴胺 抗肿瘤 医药与日化原料 hedgehog signaling pathway veratramine cyclopamine antitumor activity drug and cosmetic materials
  • 相关文献

参考文献17

  • 1Bijlsma M F,Spek C A,Peppelenbosch M P.Hedgehog:an unusual signal transducer[J].Bioessays,2004,26(4):387-394.
  • 2Lum L,Beachy P A.The Hedgehog response network:sensors,switches,and routers[J].Science,2004,304(5678):1755-1759.
  • 3Gupta S,Takebe N,Lorusso P.Targeting the Hedgehog pathway in cancer[J].Therapeutic advances in medical oncology,2010,2(4):237-250.
  • 4Dlugosz A,Agrawal S,Kirkpatrick P.Vismodegib[J].Nature reviews drug discovery,2012,11(6):437-438.
  • 5Binns W,James L F,Keeler R F,et al.Effects of teratogenic agents in range plants[J].Cancer research,1968,28(11):2323-2328.
  • 6Winkler J D,Isaacs A,Holderbaum L,et al.Design and synthesis of inhibitors of hedgehog signaling based on the alkaloid cyclopamine[J].Organic Letters,2009,11(13):2824-2827.
  • 7Zhang X,Harrington N J,Moraes R C,et al.Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened(Smo)[J].Breast Cancer Research and Treatment,2009,115(3):505-521.
  • 8Romer J T,Kimura H,Magdaleno S,et al.Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-)mice[J].Cancer Cell,2004,6(3):229-240.
  • 9Chen J K,Taipale J,Cooper M K,et al.Inhibition of Hedgehog signaling by direct binding of cyclopamine to smoothened[J].Genes&Development,2002,16(21):2743-2748.
  • 10Wilson S R,Strand M F,Krapp A,et al.Hedgehog antagonist cyclopamine isomerizes to less potent forms when acidified[J].Journal of Pharmaceutical and Biomedical Analysis,2010,52(5):707-713.

二级参考文献10

  • 1Ahaba AR, Sanchez P, Dahmane N. Gli and hedgehog in cancer: tumors, embryos and stem cells. Nature Reviews Cancer,2002,2 : 361-372.
  • 2Zhang X, Harrington N, Moraes RC, et al. Cyclopamine inhi- bition of human breast cancer cell growth independent of Smoothened ( Sine ). Breast Cancer Res Treat, 2009, 115 : 505-521.
  • 3Sasai K, Romer iT, Lee Y, et al. Shh pathway activity is down-regulated in cultured medulloblastoma cells: implica- tions for preclinical studies. Cancer Res, 2006, 66: 4215-4222.
  • 4Chen JK,Taipale J,Cooper MK,et al. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev ,2002,16:2743 -2748.
  • 5Tremblay MR, Lescarbeau A, Grogan M J, et al. Discovery of a potent and orally active hedgehog pathway antagonist ( IPI- 926). J Med Chem ,2009 ,52 :4400-4418.
  • 6Rudln A J, Miller WH, Eigl BJ, et al. A phase I study of IPI- 926,a novel hedgehog pathway inhibitor, in patients (pts) with advanced or metastatic solid tumors. J ClinOncol,2011, 29:3014.
  • 7Wintersteiner O, Moore M. Jervine. XIV. Isojervin-11 β-ol and related reduction products of isojervine. J Organ Chem, 1965,30:528-533.
  • 8Masamune T, Sato N, Kobayashi I, et al. Syntheses and NMR spectra of22,27-imino-17,23-oxidojervane derivatives. Tetra- hedron, 1967,23:1591-1612.
  • 9Giannis A, Heretsch P, Sarli V, et al. Synthesis of cyclopamine using a blomlmetic gewChemJnt Ed,2009,48:7911-7914.
  • 10Mural A, Arita K, MasamuneT. Stereochemistry of the C and D rings of C-Nor-D-homosteroids. I. The Birch reduction of Jervine-1113- ol and related compounds. Bull ChemSoc Japan, 1973,46 : 3536-3544.

共引文献4

同被引文献33

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部